2024 News
GFCS CEO takes part in US-India Cancer Dialogue
In August 2024, Dr. Chandra Are participated in the US-India Cancer Dialogue where experts addressed the spectrum of cancer care and research, from artificial intelligence (AI) innovation and novel therapeutics to clinical trials, survivorship care, and complementary and alternative medicines. The U.S.-India Cancer Dialogue provides momentum and a blueprint for future collaboration between the two countries to accelerate progress in cancer research and treatment.
ASCO Post on Sept. 3: Prescription for Progress: Lancet Oncology Commission’s practical strategies for global cancer surgery (Chandrakanth Are)
Read the conversation with Chandrakanth Are, MBBS, MBA, FRCS, FACS here.